- $4.47m
- $11.41m
- $0.59m
- 43
- 14
- 26
- 16
Annual income statement for MedWellaAI, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | C2022 June 30th | C2023 June 30th | R2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.85 | 6.55 | 3.86 | 0 | 0.595 |
| Cost of Revenue | |||||
| Gross Profit | 0.931 | 2.68 | 1.16 | 0 | 0.587 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 23.5 | 7.23 | 29 | 9.07 | 3.49 |
| Operating Profit | -21.7 | -0.682 | -25.2 | -9.07 | -2.9 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -22.4 | -0.566 | -25.5 | -9.15 | -2.95 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22.4 | -0.566 | -25.5 | -9.15 | -2.95 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -22.4 | -0.566 | -25.5 | -11.5 | -3.61 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -23 | -1.12 | -26.9 | -12 | -3.61 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -19.5 | -0.562 | -8.96 | -2.18 | -0.345 |